ArticleChemistry & biodiversity2026
Phytochemical Characterization, Molecular Docking Analysis, and In Vitro Antischistosomal Activity of Capsicum annuum Methanolic Extract.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Human schistosomiasis is a neglected tropical disease affecting millions worldwide, highlighting the need for affordable alternative therapies. This study evaluated the in vitro antischistosomal activity of the Capsicum annuum methanolic extract against adult Schistosoma mansoni. Tegumental alterations were examined by scanning electron microscopy (SEM), while potential molecular targets were investigated using STITCH network analysis, molecular docking, and in silico pharmacokinetic prediction. Concentrations of C. annuum extract (20-320 µg/mL) and praziquantel (0.2 µg/mL) were evaluated for time-dependent worm mortality at 1, 3, 12, 24, 48, and 72 h post-treatment. Praziquantel induced 100% mortality within 24 h, whereas the dose (320 µg/mL) caused 50% mortality at 24 h and complete mortality at 48 h. Docking analysis suggested apoptosis-related proteases and a Ser/Thr kinase as putative molecular targets that warrant further experimental validation. These findings demonstrate that C. annuum methanolic extract possesses promising antischistosomal activity against S. mansoni.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.